3 reports

  • V. Advanced/Stage IV/Metastatic RCC

Combination of approved immunotherapies with new in-research immunotherapies has resulted in improved response rates for patients with RCC.

  • Cancer
  • Immunotherapy
  • Renal Cancer
  • Therapy
  • Celldex Therapeutics, Inc.
  • 10.11 CELLDEX THERAPEUTICS

At the 2012 Society for Immunotherapy Annual Meeting, results from a Phase ## study of CDX-## were presented.

  • Cancer Immunotherapy
  • Immunotherapy
  • Therapy
  • Vaccine
  • Celldex Therapeutics, Inc.
  • Nov 30, 2017: Celldex Therapeutics Initiates Phase 1 Study of New Product Candidate CDX- 1140 in Solid Tumors
  • Apr 20, 2018: Celldex Therapeutics presents data on CDX-1140 at AACR Annual Meeting 2018

Initiated Phase ## study of CDX-##: A Phase ## study of CDX-## was initiated in November 2017.

  • Immunotherapy
  • Therapy
  • United States
  • Company
  • Celldex Therapeutics, Inc.